BLOG — Saisei Mirai

Saisei Hawaii
Saisei Mirai Featured in Science Featured – Telomere Research Recognized

Saisei Mirai Featured in Science Featured – Telomere Research Recognized

Dr. Inui’s research on telomere length and aging has been featured in Science Featured, recognizing Saisei Mirai’s contributions to longevity and regenerative medicine.

Read more →


Saisei Hawaii
Anti-Aging Conference 2025 – Now Available On-Demand

Anti-Aging Conference 2025 – Now Available On-Demand

The Anti-Aging Conference 2025 has concluded successfully. Full recordings are now available to watch online, featuring expert talks on longevity and biological age reversal.

Read more →


Saisei Hawaii
Saisei Mirai Clinics Anti-Aging Conference 2025 Osaka

Saisei Mirai Clinics Anti-Aging Conference 2025 Osaka

Theme: Reversing Biological Age – Rejuvenation Join us for an exciting full-day conference dedicated to the most advanced therapies and scientific breakthroughs in longevity, rejuvenation, and biological age reversal. Learn from leading global experts and discover cutting-edge strategies to improve healthspan and vitality. 📅 Date: Saturday, June 14🕥 Time: 10:30 AM – 5:00 PM📍 Venue: OMM Building,Osaka, Japan🎟 Entry: FREE 🎥 Can't attend the conference? Watch the recording!Stay inspired and informed — wherever you are. Don't miss this opportunity to hear the latest innovations and insights in the anti-aging field — from immune modulation and regenerative medicine to telomere science and Klotho gene expression. 👉 Seats are limited! Reserve your spot today.📞 Call...

Read more →


Saisei Hawaii
The Effect of MAF Capsules and M Capsules on Lymphopenia and Clinical Outcomes in Non-Critical Hospitalized COVID-19 Patients

The Effect of MAF Capsules and M Capsules on Lymphopenia and Clinical Outcomes in Non-Critical Hospitalized COVID-19 Patients

The Effect of MAF Capsules and M Capsules on Lymphopenia and Clinical Outcomes in Non-Critical Hospitalized COVID-19 PatientsPreprints with The Lancet 19 Pages Posted: 7 Feb 2023 Abstract BACKGROUND: Excessive inflammation and lymphopenia are linked to poor Covid-19 clinical outcomes. Targeting both conditions using an immunomodulating approach needs to be tested.METHODS: We conducted an open-label, randomized, controlled trial of MAF Capsules and M Capsules in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection but at enrolment did not require resuscitation or mechanical ventilation. Patients were randomly assigned to receive, in addition to standard of care...

Read more →